GlassScriptPhysician profile
Mark S Horvath
NPI 1366533036
$2,991.78
in general payments reported to CMS, 2019-2025
14 companies · $832 in 2025
The $832 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $227 · 2021: $147 · 2022: $406 · 2023: $635 · 2024: $443 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.19 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $703.55 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $397.23 | 2019-2025 | Precision7, Total30 |
| Coopervision INC. | $318.42 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $265.70 | 2019-2021 | |
| Topcon Healthcare, INC. | $227.57 | 2023 | |
| Bausch & Lomb Americas INC. | $196.00 | 2022-2025 | Infuse, Miebo, Btod |
| Sun Pharmaceutical Industries INC. | $186.14 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $144.10 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $142.79 | 2023 | |
| Allergan, INC. | $122.52 | 2022 | |
| Abb Con-Cise Optical Group LLC | $116.41 | 2019-2022 | |
| Lombart Brothers, INC. | $94.03 | 2024-2025 | Opd-III |
| Oyster Point Pharma, INC. | $44.23 | 2025 | Tyrvaya, Ryzumvi |
| Sight Sciences, INC. | $33.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Horvath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.